Earnings Feed
Start Free
Home/Filings/4/0001235802-18-000022
4//SEC Filing

Williamson Thomas P. 4

Accession 0001235802-18-000022

CIK 0001374128other
View on SEC.govCompany Profile

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 2:22 PM ET

Size

32.0 KB

Accession

0001235802-18-000022

Insider Transaction Report

Form 4
Period: 2018-02-28
ENTELLUS MEDICAL INCENTL
Williamson Thomas P.
Vice President, Sales
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2018-02-28$6.19/sh−10,000$61,900→ 0 total
    Exercise: $17.81Exp: 2025-11-04→ Common Stock (10,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2018-02-28$6.76/sh−20,000$135,200→ 0 total
    Exercise: $17.24Exp: 2027-11-04→ Common Stock (20,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2018-02-28$20.52/sh−548$11,245→ 0 total
    Exercise: $3.48Exp: 2024-06-04→ Common Stock (548 underlying)
  • Disposition to Issuer

    Common Stock, $0.001 par value

    2018-02-28$24.00/sh−44,986$1,079,664→ 0 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2018-02-28$22.76/sh−28$637→ 0 total
    Exercise: $1.24Exp: 2023-03-19→ Common Stock (28 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2018-02-28$22.76/sh−49$1,115→ 0 total
    Exercise: $1.24Exp: 2023-03-19→ Common Stock (49 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2018-02-28$20.52/sh−331$6,792→ 0 total
    Exercise: $3.48Exp: 2024-01-17→ Common Stock (331 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2018-02-28$20.52/sh−340$6,977→ 0 total
    Exercise: $3.48Exp: 2024-04-15→ Common Stock (340 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2018-02-28$2.65/sh−3,000$7,950→ 0 total
    Exercise: $21.35Exp: 2025-02-09→ Common Stock (3,000 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2018-02-28$20.52/sh−470$9,644→ 0 total
    Exercise: $3.48Exp: 2024-06-04→ Common Stock (470 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2018-02-28$12.64/sh−1,804$22,803→ 0 total
    Exercise: $11.36Exp: 2024-12-16→ Common Stock (1,804 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2018-02-28$7.16/sh−40,000$286,400→ 0 total
    Exercise: $16.84Exp: 2027-02-04→ Common Stock (40,000 underlying)
Footnotes (12)
  • [F1]Disposed of pursuant to an Agreement and Plan of Merger, dated December 7, 2017, between Entellus Medical, Inc., Stryker Corporation and Explorer Merger Sub Corp. in exchange for a cash payment of $24.00 per share.
  • [F10]This option, which provided for vesting in 48 equal month installments commencing on December 4, 2015, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
  • [F11]This option, which provided for vesting in 48 equal month installments commencing on February 5, 2017, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
  • [F12]This option, which provided for vesting in 48 equal month installments commencing on December 1, 2017, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
  • [F2]This option, which became fully vested and exercisable on January 1, 2017, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
  • [F3]This option, which became fully vested and exercisable on January 1, 2017, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
  • [F4]This option, which provided for vesting in 48 equal month installments commencing on January 17, 2014, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
  • [F5]This option, which provided for vesting in 48 equal month installments commencing on February 1, 2014, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
  • [F6]This option, which provided for vesting in 48 equal month installments commencing on July 1, 2014, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
  • [F7]This option, which provided for vesting in 48 equal month installments commencing on October 1, 2014, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
  • [F8]This option, which provided for vesting in 48 equal month installments commencing on January 16, 2015, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.
  • [F9]This option, which provided for vesting in 48 equal month installments commencing on March 9, 2015, was canceled in the merger in exchange for a cash payment equal to: (a) the number of shares of Issuer common stock underlying the option, multiplied by (b) the excess of $24.00 over the per share exercise price of such option.

Documents

1 file

Issuer

ENTELLUS MEDICAL INC

CIK 0001374128

→
Entity typeother

Related Parties

1
  • filerCIK 0001694558

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 2:22 PM ET
Size
32.0 KB
View on SEC.gov